Clinical trials
Intracerebral Hemorrhage Basal Ganglia clinical trials
Below are recruiting intracerebral hemorrhage basal ganglia clinical trials, each written for real people, not researchers. We’re tracking 15 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06484374Recruiting
AI-robot guided surgery for large basal ganglia bleeding
This trial tests a new, less invasive brain surgery using a robotic arm guided by artificial intelligence (AI) to remove a large blood clot caused by a hemorrhagic stroke in the basal ganglia. It may be an option for people who can have surgery soon after the stroke and were previously independent.
NanjingAges 18 years+ - NCT05434065RecruitingPhase 2
Celecoxib for brain bleeding after onset
This Phase 2 trial tests whether celecoxib (an anti-inflammatory medicine) can improve outcomes after an intracerebral hemorrhage (a type of stroke caused by bleeding in the brain). It also studies how the medicine may help the body recover. You would need to start treatment quickly after symptoms begin and meet several safety and bleeding-control requirements.
TaipeiAges 20–80 - NCT05539859Recruiting
Brain bleed surgery trial using endoscope for deep brain bleeding
This trial tests whether a minimally invasive brain surgery using an endoscope can improve outcomes for people with a deep brain bleed. It also studies the safety of this approach compared with standard care.
Chongqing, Chongqing MunicipalityAges 18–80 - NCT06465719Recruiting
Robot-assisted surgery for moderate brain bleeding
This trial tests if a minimally invasive surgery guided by a robotic AI system can help people with moderate bleeding deep inside the brain (basal ganglia). If you qualify, the surgery would happen within 72 hours of your stroke.
Hangzhou, ZhejiangAges 18 years+ - NCT06688201Recruiting
Minimally invasive clot removal for large brain bleed
This trial tests a minimally invasive surgery (soft channel drainage) to remove a large blood clot deep in the brain after a stroke. It is for people who can have the procedure within 48 hours of bleeding and whose consciousness is reduced but not completely gone.
Linyi, ShandongAges 18–80 - NCT07053917RecruitingPhase 1
Psilocybin therapy for stroke recovery
This trial tests whether a medicine called psilocybin (a psychedelic compound) can help people who had a stroke more than a year ago. It aims to see if the therapy can improve healing and flexibility in the brain.
Baltimore, MarylandAges 18 years+ - NCT07205263Recruiting
AI-guided minimally invasive surgery for brain bleeding
This trial tests a minimally invasive surgery guided by artificial intelligence to treat spontaneous brain bleeding. It aims to improve recovery by precisely removing the clot with less damage to healthy brain tissue.
Hangzhou, ZhejiangAges 18 years+ - NCT07234955Recruiting
Minimally invasive surgery for deep brain bleeding
This trial tests a minimally invasive surgery to remove blood clots deep in the brain after a spontaneous bleed. It may help patients with moderate to large bleeds who are at least 18 and up to 80 years old.
Ho Chi Minh City, Ho Chi MinhAges 18–80 - NCT07319013Recruiting
AI Ultrasound for Early Brain Bleed Detection
This trial uses an AI-assisted ultrasound to quickly detect brain bleeding in people with acute stroke. It may help speed up diagnosis and treatment.
Barcelona, CataloniaAges 18 years+ - NCT07260916Recruiting
Early surgery with a tiny camera for brain hemorrhage
This trial tests whether using a small camera and a tube to very quickly remove a brain bleed through a tiny hole in the skull improves recovery compared to standard medical care. It is for people who have a large, non-traumatic brain hemorrhage and can have surgery within a few hours of the bleed.
New Brunswick, New JerseyAges 18–80 - NCT06688162Enrolling by invitation
Minimally invasive surgery for small brain bleeds
This trial tests a less invasive surgery to remove small blood clots (20–30 ml) in the basal ganglia, a deep part of the brain. It may help people who are awake but have a reduced level of consciousness after a recent brain bleed.
BeijingAges 18–80 - NCT06868511RecruitingPhase 3
Minimally invasive clot removal with tenecteplase for deep brain bleed
This trial tests a minimally invasive procedure to remove deep brain bleeds using a special puncture guided by brain imaging, combined with a clot-dissolving drug called tenecteplase. It may help reduce damage from the bleed and improve recovery.
Beijing, ChinaAges 18–80 - NCT06504576RecruitingPhase 2
Testing cilostazol to clear brain bleed
This clinical trial tests whether a medication called cilostazol can help the body reabsorb a brain bleed (intracerebral hemorrhage) more quickly. It is for adults with a small bleed in a specific part of the brain (thalamus or basal ganglia) who are otherwise in good health.
Taipei, Not Required For This CountryAges 20–80 - NCT05891509Recruiting
DTI-guided minimally invasive surgery for deep brain bleeding
This trial studies whether a special scan-guided, minimally invasive procedure can safely remove bleeding in the basal ganglia (deep in the brain) soon after it happens. It may help patients recover better by targeting the bleeding while protecting important brain pathways.
Ganzhou, JiangxiAges 18–80 - NCT06843616Recruiting
Study of a disposable brain clot removal scope for bleeding stroke
This study tests a new disposable tube with a camera (endoscope) that doctors use to remove a blood clot from the brain after a bleeding stroke. It is designed for people who are stable enough for surgery and whose bleed is in a part of the brain that is reachable with this tool.
Guiyang, GuizhouAges 18–80
Hear when a new Intracerebral Hemorrhage Basal Ganglia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for intracerebral hemorrhage basal ganglia?
- Yes. Clin2 currently lists 15 recruiting intracerebral hemorrhage basal ganglia studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a intracerebral hemorrhage basal ganglia trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a intracerebral hemorrhage basal ganglia trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.